Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Starting with comprehensive testing and insights from the worlds top doctors
For researchers investigating cellular senescence, aging biology, regenerative medicine, and age-related diseases, FOXO4-DRI offers a sophisticated tool that combines mechanistic precision with practical utility, enabling advancement in our understanding of senescence biology and the development of innovative approaches to studying aging and developing research tools for age-related cellular dysfunction
Cardiovascular disease is considered as one of the main causes of mortality for diabetic patients (Stamler et al., 1993)
Consequently, there is considerable interest in developing strategies to protect this AA from ruminal degradation and deliver it directly to the intestine
CagriSema CagriSema is an investigational fixed-dose combination of cagrilintide, a long-acting amylin analog, and semaglutide, a GLP-1 receptor agonist, co-administered once weekly and studied in Phase 3 trials for obesity and type 2 diabetes.
US$ 25.42
US$ 27.08
US$ 26.11
US$ 28.05
US$ 21.91
US$ 23.30
US$ 25.30
